Leonard B Saltz MD

Oncology•New York, NY

Professor of Medicine, Cornell University-Weill Medical College

Request appointment

160 East 53rd StreetNew York, NY 10022
Book by Phone+1(448) 208-1132

Overview of Dr. Saltz

Dr. Leonard Saltz is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, New York-Presbyterian Hospital, and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Yale School of Medicine and has been in practice 43 years. Dr. Saltz accepts several types of health insurance, listed below. He is one of 529 doctors at Memorial Sloan Kettering Cancer Center and one of 66 doctors at NYC Health + Hospitals / Bellevue who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1983 - 1986
Yale School of MedicineClass of 1983

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2021 - Present
CT State Medical License 2023 - 2027
NJ State Medical License 2020 - 2027
NY State Medical License 1985 - 2027
PA State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
Super Doctor SuperDoctors.com

Clinical Trials

Irinotecan in Treating Patients With Metastatic Colorectal Cancer
COMPLETED
PHASE2
Combination Chemotherapy in Treating Patients With Advanced Cancer
COMPLETED
PHASE1
Irinotecan in Treating Patients With Advanced Solid Tumors
COMPLETED
PHASE1

Publications & Presentations

PubMed

Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-Derived external control arms.
Morteza Raeisi, Thierry André, Qian Shi, Takayuki Yoshino, Richard Adams
Journal of the National Cancer Institute. 2026-08-22
Molecular Lineages of Sporadic Mismatch Repair-Deficient Colorectal Cancer.
Michael B Foote, Guilherme Harada, Somer Abdelfattah, Nil Urganci, Paolo Manca
Clinical Cancer Research. 2026-07-17
Does Radiation Boost Dose Affect Organ Preservation Rates? A Secondary Analysis of the Organ Preservation in Patients With Rectal Adenocarcinoma Trial.
Orly Yariv, Hannah Williams, Karyn A Goodman, Floris S Verheij, Dana M Omer
International Journal of Radiation Oncology, Biology, Physics. 2026-05-15

Journal Articles

Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19
Mark J Ratain, Leonard B Saltz, JAMA Oncology
Pelvic MRI After Induction Chemotherapy and Before Long-Course Chemoradiation Therapy for Rectal Cancer: What Are the Imaging Findings?
Andrea Cercek, Leonard Saltz, Marc J Gollub, Patricio Lynn, Martin R Weiser, European Radiology

Lectures

Value Propositions in Colorectal Cancer
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
Counterpoint: We Need to be Highly Selective in the Patients We Test
2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Selected Updates in Colorectal Cancer
2007 Annual Meeting, Chicago, Illinois, USA

Authored Content

Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19May 2020

Press Mentions

Pre-Op Aflibercept Ups Response in High-Risk Rectal CancerAugust 29th, 2019
Combo Immunotherapy Failed to Improve Outcomes in MSS Colorectal CancerApril 30th, 2019
Dr. Saltz Discusses Chemotherapy in Metastatic CRCDecember 12th, 2017

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment